Epstein Secrets

Fear FDA's Hahn Unable To Withstand Political Pressure. The New York Times <https://www.nytimes.corn/2020/08/10/health/stephen-hahn-fda.html> (8/10, Kaplan, 18.61 M) reports that "many medical experts — including members of his own staff— worry about whether" FDA Commissioner Hahn "has the fortitude an

as `unsuitable' for the post of President Trump's national security adviser." Halper told Schrage, "I don't think Flynn's going to be around long." Halper's comments to Schrage, who was a doctoral candidate at Cambridge at the time, "were recorded on Jan. 10, 2017, two days before a Washington Post col

agree on who an independent expert is." NYTimes Analysis: Critics Fear FDA's Hahn Unable To Withstand Political Pressure. The New York Times (8/10, Kaplan, 18.61M) reports that "many medical experts - including members of his own staff — worry about whether" FDA Commissioner Hahn "has the fortitude an

ambridge professor told him that retired Army Lt. Gen. Michael Flynn was 'unsuitable' for the post of President Trump's national security adviser." Halper told Schrage, "I don't think Flynn's going to be around long." Halper's comments to Schrage, who was a doctoral candidate at Cambridge at the time,

criminal justice systems.' Reuters suggests the proposals are an attempt to build support "among black voters." The New York Times (8/20, Williams, Kaplan, 18.61M) reports, "Democratic candidates are pushing ideas that were considered radical just a few years ago. But the American public has changed it

oiled an innocent woman' — her — 'in a conspiracy to undo the 2016 presidential election and topple the president of the United States of America.'" Halper, a Cambridge professor and an FBI informant against Trump's campaign, "demanded the claims in the US District Court of Eastern Virginia filed in May

agree on who an independent expert is." NYTimes Analysis: Critics Fear FDA's Hahn Unable To Withstand Political Pressure. The New York Times (8/10, Kaplan, 18.61M) reports that "many medical experts - including members of his own staff - worry about whether" FDA Commissioner Hahn "has the fortitude an

ambridge professor told him that retired Army Lt. Gen. Michael Flynn was 'unsuitable' for the post of President Trump's national security adviser." Halper told Schrage, "I don't think Flynn's going to be around long." Halper's comments to Schrage, who was a doctoral candidate at Cambridge at the time,